Mecasermin Terminated Phase 1 / 2 Trials for Growth Failure / Growth Hormone Resistence / X-linked Severe Combined Immunodeficiency (XSCID) Treatment

IndicationsStatusPurposePhase
TerminatedTreatment1 / 2
clinicaltrials.gov IdentifierTitleDrugs